Understanding Non-Hodgkin Lymphoma

How Can Experts Overcome Language and Cultural Barriers to Increase Clinical Trial Participation?

How are researchers helping to improve participation by minorities in clinical trials? Watch as expert Dr. Richard Schilsky discusses language and cultural barriers.

Published:

Why Are Minorities Often Underrepresented in Clinical Trials?

How can ethnic minorities gain access to more clinical trials? Watch as clinical trial experts Dr. Richard Schilsky and Cecelia Mann share their perspectives.

Published:

Addressing a History of Fears About Clinical Trials: An Expert Weighs In

How are cancer patients cared for in clinical studies? Tune in to hear expert Dr. Richard Schilsky explain patient consent and safety, clinical trial regulation and more.

Published:

What Is the Role of Mindfulness in Cancer Care?

How are mindfulness-based practices used in cancer care? Watch as expert Dr. Ruben Mesa explains how techniques can help with stress reduction, managing uncertainty and more.

Published:

Dear Stacey: Are There Costly Consequences to Co-Pay Accumulator Programs?

What is a co-pay accumulator, and how will it affect cancer patients access to treatment? Noted healthcare attorney Stacey Worthy discusses what patients need to know about the “double-dip” insurance deductible.

Published:

Follicular Lymphoma Updates From ASH 2018

Dr. Neel Gupta speaks with Andrew Schorr about new and improving therapies for follicular lymphoma from ASH 2018.

Published:

Follicular Lymphoma News at ASH 2018: An Update From Dr. Peter Martin

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Patient Power founder Andrew Schorr is joined by leading expert Dr. Peter Martin to discuss follicular lymphoma treatment news announced at the conference. Watch now to stay up-to-date with the latest research.

Published:

Peripheral T-Cell Lymphoma Updates From ASH 2018 With Dr. Gupta

Lee Swanson is joined by Dr. Neel K. Gupta of Stanford University School of Medicine. They discuss changes since last year’s ASH meeting.

Published:

Updates From ASH 2018 Peripheral T-Cell Lymphoma With Dr. Horwitz

Dr. Steven Horwitz joins Lee Swanson to discuss new approvals and advancements made in peripheral T-cell lymphoma at ASH 2018. Dr. Steven Horwitz has been instrumental in these studies leading to approval for new treatments.

Published:

Showing 9 of 93 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 27, 2018